A Stable ETF to Gain Exposure to a Volatile Biotech Sector

After biotech stocks tumbled in the wake of drug pricing concerns and a disdain for growth stocks, biotechnology exchange traded funds show cheaper valuations and possibly present a buying opportunity for investors. “The recent price pressure may present a buying opportunity for investors...